» Articles » PMID: 12136128

Altered Glycan-dependent Signaling Induces Insulin Resistance and Hyperleptinemia

Overview
Specialty Science
Date 2002 Jul 24
PMID 12136128
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance and beta cell toxicity are key features of type 2 diabetes. One leading hypothesis suggests that these abnormalities result from excessive flux of nutrients through the UDP-hexosamine biosynthetic pathway leading to "glucose toxicity." How the products of the hexosamine pathway mediate these effects is not known. Here, we show that transgenic overexpression of an enzyme using UDP-GlcNAc to modify proteins with O-GlcNAc produces the type 2 diabetic phenotype. Even modest overexpression of an isoform of O-GlcNAc transferase, in muscle and fat, leads to insulin resistance and hyperleptinemia. These data support the proposal that O-linked GlcNAc transferase participates in a hexosamine-dependent signaling pathway that is linked to insulin resistance and leptin production.

Citing Articles

Genetic gradual reduction of OGT activity unveils the essential role of O-GlcNAc in the mouse embryo.

Formichetti S, Sadowska A, Ascolani M, Hansen J, Ganter K, Lancrin C PLoS Genet. 2025; 21(1):e1011507.

PMID: 39787076 PMC: 11717234. DOI: 10.1371/journal.pgen.1011507.


Interplay Between Metabolic Pathways and Increased Oxidative Stress in Human Red Blood Cells.

Spinelli S, Marino A, Morabito R, Remigante A Cells. 2024; 13(23).

PMID: 39682773 PMC: 11640724. DOI: 10.3390/cells13232026.


The post-translational modification O-GlcNAc is a sensor and regulator of metabolism.

Morales M, Pratt M Open Biol. 2024; 14(10):240209.

PMID: 39474868 PMC: 11523104. DOI: 10.1098/rsob.240209.


Diabetes mellitus-Progress and opportunities in the evolving epidemic.

Abel E, Gloyn A, Evans-Molina C, Joseph J, Misra S, Pajvani U Cell. 2024; 187(15):3789-3820.

PMID: 39059357 PMC: 11299851. DOI: 10.1016/j.cell.2024.06.029.


Role of O-linked N-acetylglucosamine protein modification in oxidative stress-induced autophagy: a novel target for bone remodeling.

Li S, Ren W, Zheng J, Li S, Zhi K, Gao L Cell Commun Signal. 2024; 22(1):358.

PMID: 38987770 PMC: 11238385. DOI: 10.1186/s12964-024-01734-3.


References
1.
Considine R, Cooksey R, Williams L, Fawcett R, Zhang P, Ambrosius W . Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metab. 2000; 85(10):3551-6. DOI: 10.1210/jcem.85.10.6916. View

2.
Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L . A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature. 1998; 393(6686):684-8. DOI: 10.1038/31474. View

3.
Hanover J, Lai Z, Lee G, Lubas W, Sato S . Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells. Arch Biochem Biophys. 1999; 362(1):38-45. DOI: 10.1006/abbi.1998.1016. View

4.
Cooksey R, Hebert Jr L, Zhu J, Wofford P, Garvey W, McClain D . Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology. 1999; 140(3):1151-7. DOI: 10.1210/endo.140.3.6563. View

5.
Coleman R, Herrmann T . Nutritional regulation of leptin in humans. Diabetologia. 1999; 42(6):639-46. DOI: 10.1007/s001250051210. View